Polyamine catabolism contributes to enterotoxigenic<i>Bacteroides fragilis</i>-induced colon tumorigenesis
-
- Andrew C. Goodwin
- Departments of aOncology,
-
- Christina E. Destefano Shields
- Departments of aOncology,
-
- Shaoguang Wu
- Medicine,
-
- David L. Huso
- Molecular and Comparative Pathobiology, and
-
- XinQun Wu
- Medicine,
-
- Tracy R. Murray-Stewart
- Departments of aOncology,
-
- Amy Hacker-Prietz
- Departments of aOncology,
-
- Shervin Rabizadeh
- Pediatrics and The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21231; and
-
- Patrick M. Woster
- Department of Pharmaceutical and Biomedical Sciences, Medical Univeristy of South Carolina, Charleston, SC 29425
-
- Cynthia L. Sears
- Departments of aOncology,
-
- Robert A. Casero
- Departments of aOncology,
書誌事項
- 公開日
- 2011-08-29
- DOI
-
- 10.1073/pnas.1010203108
- 公開者
- Proceedings of the National Academy of Sciences
この論文をさがす
説明
<jats:p>It is estimated that the etiology of 20–30% of epithelial cancers is directly associated with inflammation, although the direct molecular events linking inflammation and carcinogenesis are poorly defined. In the context of gastrointestinal disease, the bacterium enterotoxigenic<jats:italic>Bacteroides fragilis</jats:italic>(ETBF) is a significant source of chronic inflammation and has been implicated as a risk factor for colorectal cancer. Spermine oxidase (SMO) is a polyamine catabolic enzyme that is highly inducible by inflammatory stimuli resulting in increased reactive oxygen species (ROS) and DNA damage. We now demonstrate that purified<jats:italic>B. fragilis</jats:italic>toxin (BFT) up-regulates SMO in HT29/c1 and T84 colonic epithelial cells, resulting in SMO-dependent generation of ROS and induction of γ-H2A.x, a marker of DNA damage. Further, ETBF-induced colitis in C57BL/6 mice is associated with increased SMO expression and treatment of mice with an inhibitor of polyamine catabolism,<jats:italic>N</jats:italic><jats:sup>1</jats:sup>,<jats:italic>N</jats:italic><jats:sup>4</jats:sup>-bis(2,3-butandienyl)-1,4-butanediamine (MDL 72527), significantly reduces ETBF-induced chronic inflammation and proliferation. Most importantly, in the multiple intestinal neoplasia (Min) mouse model, treatment with MDL 72527 reduces ETBF-induced colon tumorigenesis by 69% (<jats:italic>P</jats:italic>< 0.001). The results of these studies indicate that SMO is a source of bacteria-induced ROS directly associated with tumorigenesis and could serve as a unique target for chemoprevention.</jats:p>
収録刊行物
-
- Proceedings of the National Academy of Sciences
-
Proceedings of the National Academy of Sciences 108 (37), 15354-15359, 2011-08-29
Proceedings of the National Academy of Sciences
